title: Nitric oxide contributes to hypoxia-reoxygenation-induced P-glycoprotein expression in rat brain endothelial cells.
abstract: Ischemia-reperfusion leads to increased levels at the blood-brain barrier of the multidrug efflux transporter, P-glycoprotein that provides protection to the brain by limiting access of unwanted substances. This is coincident with the production of nitric oxide. This present study using immortalized rat brain endothelial cells (GPNTs) examines whether following hypoxia-reoxygenation, nitric oxide contributes to the alterations in P-glycoprotein levels. After 6 h of hypoxia, both nitric oxide and reactive oxygen species, detected intracellularly using fluorescent monitoring dyes, were produced in the subsequent reoxygenation phase coincident with increased P-glycoprotein. The evidence that nitric oxide can directly affect P-glycoprotein expression was sought by applying S-nitroso-N-acetyl-DL: -penicillamine that as shown increased the nitric oxide generation. Sodium nitroprusside, though more effective at increasing P-glycoprotein expression, appeared to produce different reactive species. Real time RT-PCR analysis revealed the predominant form of nitric oxide synthase in these cells to be endothelial, inhibition of which partially prevented the increase in P-glycoprotein during reoxygenation. These data indicate that the production of nitric oxide by endothelial nitric oxide synthase during reoxygenation can influence P-glycoprotein expression in cells of the blood-rat brain barrier, highlighting another route by which nitric oxide may protect the brain.
authors: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.
authors: Samantha J
authors: SJ
authors: Robertson
authors: Ruth
authors: R
authors: Mokgokong
authors: Katarzyna D
authors: KD
authors: Kania
authors: Anne-Sophie
authors: AS
authors: Guedj
authors: Stephen B
authors: SB
authors: Hladky
authors: Margery A
authors: MA
authors: Barrand
references: Neurobiol Dis. 1996 Feb;3(1):64-71
references: 9173913
references: J Anat. 2002 Jun;200(6):629-38
references: 12162730
references: J Neuroimmunol. 1996 Dec;71(1-2):51-63
references: 8982103
references: Cardiovasc Res. 2007 Jul 15;75(2):247-60
references: 17466957
references: J Cereb Blood Flow Metab. 1996 Sep;16(5):981-7
references: 8784243
references: J Neurochem. 2003 Nov;87(4):1043-51
references: 14622133
references: Biochim Biophys Acta. 1999 Sep 20;1455(1):23-34
references: 10524226
references: Br J Pharmacol. 1999 May;127(2):546-52
references: 10385257
references: J Neurochem. 2009 Oct;111(1):132-41
references: 19656260
references: Drug Metab Dispos. 2007 Nov;35(11):1996-2005
references: 17664251
references: J Cereb Blood Flow Metab. 1995 May;15(3):378-84
references: 7536197
references: J Neurosci. 1996 Apr 15;16(8):2479-87
references: 8786424
references: Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G533-40
references: 15486347
references: FEBS Lett. 1998 May 8;427(2):263-6
references: 9607324
references: Nat Neurosci. 2006 Apr;9(4):487-8
references: 16565717
references: Cell. 1994 May 20;77(4):491-502
references: 7910522
references: Free Radic Biol Med. 2005 Aug 1;39(3):327-35
references: 15993331
references: Stroke. 1993 Nov;24(11):1709-16
references: 7694393
references: J Cereb Blood Flow Metab. 1993 May;13(3):355-8
references: 8478395
references: Eur J Pharmacol. 2000 Jul 14;400(1):19-33
references: 10913581
references: J Neurochem. 2002 Jan;80(1):64-72
references: 11796744
references: J Neurosci. 1997 Dec 1;17(23):9157-64
references: 9364062
references: Neuropeptides. 2008 Oct-Dec;42(5-6):593-600
references: 18990443
references: J Neurochem. 1999 Nov;73(5):1954-63
references: 10537053
references: Nitric Oxide. 1997 Apr;1(2):145-57
references: 9701053
references: Ann Neurol. 2006 Nov;60(5):489-498
references: 17048260
references: Stroke. 1996 Aug;27(8):1381-5
references: 8711806
references: Mol Pharmacol. 2007 Mar;71(3):667-75
references: 17132686